Please login to the form below

Not currently logged in
Email:
Password:

GSK execs offered consolation payoffs

Two GSK executives may receive significant consolation prizes for not becoming the firm's new CEO, according to UK media reports

Two GlaxoSmithKline (GSK) executives could receive significant consolation prizes for not becoming the firm's new CEO, according to UK media reports.

Chris Viehbacher, who is president of US Pharmaceuticals, and David Stout, who leads pharmaceuticals worldwide, were part of a shortlist of candidates vying for the CEO role which was eventually won by Andrew Whitty.

Both were offered approximately USD 4m in stock and cash and seats on GSK's board to keep them at the company, according to the Sunday Times and the Daily Telegraph who refused to name any sources.

A GSK spokesperson at the company's US headquarters at Research Triangle Park (RTP) in North Carolina made no comment.

Viehbacher is the highest-ranking executive at RTP, while Stout works in Philadelphia. Both were in competition with Whitty to replace Jean-Pierre Garnier, who is set to retire in May 2008.

According to the reports, shareholders have yet to approve the retention packages, which coincide with cost-cutting measures to close sites and slash jobs at RTP and at a manufacturing site nearby. GSK employs about 6,000 people at RTP.

4th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics